iShares Nasdaq Biotechnology ETF (IBB)

Add to Watchlists
Create an Alert
107.59 +0.25  +0.23% NASDAQ May 25, 16:48 Delayed 2m USD
View Full Chart
IBB Price Chart

IBB Performance

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 3.94% 3.93% 3.93% 71
3M -3.02% -3.10% 1.25% 91
6M 3.25% 3.21% 8.63% 84
YTD 0.53% 0.52% 6.46% 88
1Y 10.96% 10.95% 18.11% 67
3Y -3.84% -3.84% 3.61% 95
5Y 12.44% 12.42% 13.76% 60
10Y 15.61% 15.62% 13.38% 23
As of May 24, 2018. Returns for periods of 1 year and above are annualized.

IBB Asset Allocation

Type % Net % Long % Short
Cash 0.08% 0.08% 0.00%
Stock 99.92% 99.92% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of May 22, 2018

IBB Region Exposure

Americas 97.14%
North America 97.14%
Latin America 0.00%
Greater Europe 2.49%
United Kingdom 0.78%
Europe Developed 1.68%
Europe Emerging 0.00%
Africa/Middle East 0.03%
Greater Asia 0.37%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.37%
Market Classification
% Developed Markets 99.63%
% Emerging Markets 0.37%
As of May 22, 2018. Region breakdown data is calculated by using the long position holdings of the portfolio.

IBB Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.06%
Energy 0.00%
Financial Services 0.00%
Healthcare 99.88%
Industrials 0.00%
Real Estate 0.00%
Technology 0.05%
Utilities 0.00%
As of May 22, 2018

IBB Stock Market Capitalization

Giant 14.89%
Large 37.58%
Medium 24.48%
Small 19.32%
Micro 3.73%
As of May 22, 2018

IBB Stock Style Exposure

Large Cap Value 20.35%
Large Cap Blend 8.24%
Large Cap Growth 26.36%
Mid Cap Value 0.00%
Mid Cap Blend 2.76%
Mid Cap Growth 21.26%
Small Cap Value 1.31%
Small Cap Blend 6.55%
Small Cap Growth 13.15%
As of May 22, 2018
View More Holdings

IBB Top 10 Holdings

Symbol Name % Weight Price % Chg
AMGN Amgen Inc 7.87% 178.24 +0.16%
BIIB Biogen Inc 7.85% 286.09 +0.59%
CELG Celgene Corp 7.13% 78.70 -1.06%
GILD Gilead Sciences Inc 6.99% 67.33 -0.30%
VRTX Vertex Pharmaceuticals Inc 5.36% 157.52 +0.35%
ILMN Illumina Inc 4.82% 266.26 -1.69%
REGN Regeneron Pharmaceuticals Inc 3.73% 293.73 -0.30%
ALXN Alexion Pharmaceuticals Inc 3.63% 117.72 +0.50%
MYL Mylan NV 2.89% 39.37 +0.10%
BMRN Biomarin Pharmaceutical Inc 2.12% 92.48 +4.76%
As of May 22, 2018
Advertisement

IBB One Page Reports

IBB Basic Info

Style
Equity Style Mid Cap/Growth
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Technology
Fund Owner Firm Name iShares
Benchmark Index
NASDAQ Biotechnology TR USD
100.0%

IBB Manager Info

Name Tenure
Alan Mason 2.04 yrs
Diane Hsiung 10.34 yrs
Greg Savage 10.34 yrs
Jennifer Hsui 5.75 yrs

IBB Net Fund Flows

1M -230.59M
3M -980.83M
6M -1.007B
YTD -1.164B
1Y -77.20M
3Y 1.003B
5Y 2.930B
10Y 3.271B
As of April 30, 2018

IBB Risk Info

Beta (5Y) 1.288
Max Drawdown (All) 62.85%
Historical Sharpe (10Y) 0.7997
Historical Sortino (All) 0.5576
30-Day Rolling Volatility 17.90%
Daily Value at Risk (VaR) 1% (All) 4.84%
Monthly Value at Risk (VaR) 1% (All) 19.54%

IBB Fundamentals

Dividend Yield TTM (5-25-18) 0.42%
SEC Yield (4-30-18) 0.13%
Weighted Average PE Ratio 28.30
Weighted Average Price to Sales Ratio 6.084
Weighted Average Price to Book Ratio 4.995
Weighted Median ROE 1.28%
Weighted Median ROA -6.65%
Forecasted Dividend Yield 0.54%
Forecasted PE Ratio 15.04
Forecasted Price to Sales Ratio 4.838
Forecasted Price to Book Ratio 3.522
Number of Holdings 194
As of May 22, 2018

IBB Growth Estimates

Forecasted 5 Yr Earnings Growth 13.80%
Forecasted Book Value Growth 13.64%
Forecasted Cash Flow Growth 4.23%
Forecasted Earnings Growth -11.84%
Forecasted Revenue Growth 11.21%
As of May 22, 2018

IBB Comparables

Edit

IBB Attributes

Key Dates
Inception Date 2/5/2001
Termination Date
Last Annual Report Date 3/31/2017
Last Prospectus Date 12/1/2017
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan Yes
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

IBB Excel Add-In Codes

  • Name: =YCI("IBB","name")
  • Broad Asset Class: =YCI("IBB", "broad_asset_class")
  • Broad Category: =YCI("IBB", "broad_category_group")
  • Prospectus Objective: =YCI("IBB", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.